The Ideal Q4 revenueIf we can report another 20% increase and go up to 76M for the cannabis revenue , meaning we exclude CC Pharma, we would then beat Aurora cannabis revenue. That would make us look really good because I expect also Aphria to stay Ebidta positif like they did for the last 4 quarters. That's something Aurora and Canopy have not been able to do yet.
If we can beat Aurora Cannabis revenue just with the cannabis revenue next quarter, the share price will receive alot of appreciation.
I believe we can if you read the last post I made
https://stockhouse.com/companies/bullboard?symbol=t.apha&postid=31136595